Forbes: Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs

What a treat to speak to my former student Forbes writer Katie Jennings about the significance of a successful vaccine using mRNA platform. We could have two by early 2021. Read the story here.